| Date | Title | Description |
| 05.06.2020 | Covid-19 is changing the game for health care companies and investors | Even as the health care industry has stepped up with an unprecedented response to the Covid-19 pandemic, health care companies are being undermined by a loss of revenue, splintering of their clinical workforces, and the disintegration of no... |
| 17.12.2019 | Velano raises $15M to go beyond non-invasive blood tests | This is the second fundraising for the company this year, which now has over $50M
For most of us, getting blood drawn is an unpleasant, but necessary, part of life. For others, though, it's extremely risky, if not impossible. Those people h... |
| 17.12.2019 | Velano Vascular reels in $25M to keep building blood-draw business | “We refer to it as the one-stick hospitalization,” Eric Stone, Velano Vascular’s CEO, said in a phone interview. “Our aim, and I’ve been very open about this, is to make PIVO the standard of care around the world,” he said.
More than a bill... |
| 17.12.2019 | Velano Vascular Closes Second Tranche of $25M Growth Financing | Velano Vascular, a San Francisco, Calif. – based vascular access technology company, closed the second tranche of a $25m growth financing.
This new investment builds on an initial tranche closed in the first half of 2019 and brings total fu... |
| 17.12.2019 | Velano taps $25M in new funding for its needle-free, bedside blood draw system | Velano Vascular, maker of a needle-free blood draw system, has closed a second tranche of new financing with $25 million to put toward its commercialization and launch of additional access products and medical devices for the inpatient sett... |
| 17.12.2019 | Velano taps $25M in new funding for its needle-free, bedside blood draw system | Velano Vascular, maker of a needle-free blood draw system, has closed a second tranche of new financing with $25 million to put toward its commercialization and launch of additional access products and medical devices for the inpatient sett... |
| 09.05.2019 | Daily funding roundup - May 9th, 2018 | Humanpredictions raised $1M; Chipper Cash landed $2.4M; Stratio closed $2.5M; Intello secured $3M
Humanpredictions: Humanpredictions is a sourcing solution focused on hiring technical talent and differentiated by its rich data that allows i... |
| 08.05.2019 | Term Sheet — Wednesday, May 8 | THE $1 BILLION LOSS
2019 will be Lyft’s “peak loss year.” The ride-hailing giant has issued its first results as a public company, showing both strong growth and widening losses.
Paid Content How can you protect what you can't see? From Ext... |
| 08.05.2019 | Velano Vascular Secures $10M |
SAN FRANCISCO, CA, Velano Vascular today announced that it has secured $10 million.
>> Click here for more funding data on Velano Vascular
>> To export Velano Vascular funding data to PDF and Excel, click here
Vascular ac... |
| 08.05.2019 | Velano Vascular Raises $10M for FDA-Cleared Needle-Free Blood Draw Device | PIVO: FDA-Cleared Needle-Free Blood Draw Device
Velano Vascular, a San Francisco, CA-based vascular access technology innovator today announced that it has raised $10 million from strategic investor Intermountain Healthcare following the sy... |
| 08.05.2019 | Velano raises $10M to take the needle out of blood draws | Rather than sticking patients with needles, Velano's technology takes blood from a peripheral IV
Nobody likes getting a blood test; at least I can say that I've never met anyone who does. Beyond just being unpleasant, though, they're also o... |
| 08.05.2019 | Velano Vascular Secures $10M as Initial Tranche of Growth Financing | Velano Vascular, a San Francisco, Calif.–based access technology company, secured $10m as the initial tranche of a growth financing.
Backers included:
– Intermountain Healthcare, which previously collaborated with Velano Vascular to test, r... |
| 08.02.2018 | One of StartUp PHL’s original investments is finally out of stealth mode | How old is the longest, still-active email thread in your inbox?
This reporter’s longest-running convo since 2016 is a chat with the cofounders of stealth-mode startup Termaxia that started July 20, 2016. I reached out to inquire about what... |
| 07.03.2017 | Velano Vascular raises $17 million for a needle-free blood draw device | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Blood drawing and testing may have been tainted b... |
| 07.03.2017 | Term Sheet — Tuesday, March 7 | PRIVATE EQUITY’S TRUMP PROBLEM
Good morning. In today’s guest column, Fortune editor Stephen Gandel examines the pitfalls of a Trump presidency for private equity execs. Follow him on Twitter here.
Paid Content You can't secure what you can... |
| 07.03.2017 | Velano Vascular Raises $17M in Funding | Velano Vascular, a San Francisco, CA-based developer of human-centered vascular access technologies, secured $17m in financing.
Backers included a publicly traded healthcare company and a global supplier, which joined existing investors Fir... |
| 07.03.2017 | Velano Vascular Raises $17M |
SAN FRANCISCO, CA, Velano Vascular announced today that it has secured $17 million in financing.
>> Click here for more funding data on Velano Vascular
>> To export Velano Vascular funding data to PDF and Excel, click here
... |
| 23.02.2017 | Seventh Sense gets first FDA clearance for enclosed blood collection device | That’s the pilot test but there is a lot more to come, said Howard Weisman, CEO of the Boston, Massachusetts-based company.
The enclosed system acts as both needle and vial. Weisman hopes it will soon be approved for use without a trained s... |
| 12.12.2016 | Startup Spotlight: A new way to draw blood in hospitals | This hasn’t been a great year for companies promising to revolutionize blood draws. But startup Velano Vascular is no Theranos. The company, based in San Francisco, has received positive notice for its FDA-approved device, dubbed PIVO, whic... |
| 09.12.2016 | A Partnership Ripe for the Region | At Philly Startup Leaders’ Founder Factory event yesterday, the $6M Ben Franklin/Independence Health Group/Safeguard digital health funding initiative was announced. Safeguard’s David Luk shared the organization’s perspective on why the tim... |
| 08.12.2016 | A $6M fund will support early stage digital health startups in Philly region | Each of the fund partners contributed $2 million to the fund. They will also be responsible for sourcing potential companies for investment and provide guidance and support to these seed stage companies, the news release said.
Startups will... |
| 29.11.2016 | Velano Vascular partners with Sutter Health to scale novel blood draw device business | Slowly, the Sutter Health network is taking steps in that direction by using the PIVO, an FDA-cleared device that uses a patient’s existing, peripheral IV line to draw blood. In the surgical unit at Alta Bates Summit Medical Center in Berke... |
| 20.07.2016 | The city is making big changes to StartUp PHL | After a three-year run under First Round Capital, StartUp PHL — the city initiative to directly invest in Philadelphia’s startup ecosystem — is shutting down its existing venture fund. City officials are now searching for a new fund manager... |
| 20.05.2016 | This Startup Aims to Reduce the Need for Needles for Blood Draws | Startups that aim to cut back on the use of needles for blood draws may face some skepticism these days—the unfortunate legacy of troubled unicorn Theranos.
But Velano Vascular, a tiny San Francisco outfit launched in 2012, bears little res... |
| 14.04.2016 | UH Case Medical Center partners with Velano Vascular for use of needleless blood draw device | There are multiple reasons why a needleless blood draw is beneficial. Many people are afraid of needles, not just children, they can be painful and some people have difficult-to-access or fragile veins. But there are also safety concerns. T... |
| 10.02.2016 | Velano Vascular Raises $3.5M in Funding | Velano Vascular, a San Francisco, CA-based medical technology company which aims to enhance the care experience for hospitalized patients and their practitioners, raised an additional $3.5m in funding.
Backers included existing investors Fi... |
| 08.02.2016 | Velano Vascular has raised $3.5M to further develop and commercialize its blood draw device | This provides many benefits. For one, a lot of people are afraid of needles, especially kids (pediatrics is a big focus for Velano). Also, it prevents risks of infection for patients, it lowers the risk of practitioner infection from accide... |
| 09.02.2015 | UPDATE: Velano Vascular raises $5m, wins FDA nod for ‘needle-less’ blood-drawing device | Velano Vascular, which raised a $5 million Series A round, said today that it won 510(k) clearance from the FDA for its “needle-less” blood-drawing device.
The Velano device is designed to reduce the number of blood draws for hospitalized p... |
| 05.02.2015 | Velano Vascular Raises $5M Series A |
PHILADELPHIA, PA, Medical technology company with the goal of reducing needle sticks during the inpatient blood draw procedure, today announced that the company has closed a $5 million in Series A.
>> Click here for more funding da... |
| 05.02.2015 | Velano Vascular Closes $5M Series A Financing | Velano Vascular, a Philadelphia, PA and San Francisco, CA-based medical technology company, closed a $5m Series A financing.
Backers included First Round Capital, White Owl Capital, Kapor Capital, and Safeguard Scientifics (NYSE: SFE), in a... |
| 12.11.2014 | Medical device startup benefits from Philadelphia seed fund | The two funds are intended to give startups more incentive to stay in the city. Although Philadelphia’s startup ecosystem is growing steadily, it has lacked the investment infrastructure that has made places such as San Francisco, Boston an... |
| 11.11.2014 | City-backed StartUp PHL to announce new angel fund. Here’s why | One year after its first and only public investment to date, the City of Philadelphia’s StartUp PHL fund for local early-stage startups will announce tomorrow four new investments totaling $700,000.
The startups are vendor payment company T... |
| - | Velano Vascular reels in $25M to keep building blood-draw business | Velano Vascular has closed on $25 million in funding that will help the company advance its goal of transforming how blood is drawn from hospital patients.
The company’s chief product is called the PIVO. The FDA-approved device allows provi... |
| - | Velano Vascular has raised $3.5M to further develop and commercialize its blood draw device | Velano Vascular is expanding development and commercialization of its inpatient blood-draw technology. The company announced today it’s moving forward with $3.5 million in funding, an addition to its $5 million Series A.
The technology is d... |
| - | Seventh Sense gets first FDA clearance for enclosed blood collection device | Seventh Sense Biosystems’ TAP device
Good news for people that are afraid of needles and/or blood.
On Thursday the U.S. FDA cleared Seventh Sense Biosystem’s TAP phlebotomy device for use in hemoglobin A1c (HbA1c) testing, a standard parame... |
| - | A $6M fund will support early stage digital health startups in Philly region | Safeguard Scientifics and Independence Health Group, the parent company of insurer Independence Blue Cross, have teamed up with Ben Franklin Technology Partners of Southeastern Pennsylvania to set up a $6 million fund. The fund will be used... |
| - | UH Case Medical Center partners with Velano Vascular for use of needleless blood draw device | The idea of a needleless blood draw can inspire an inquisitive head tilt initially. How does that work? But Velano Vascular has created an innovative way to do just that with its disposable needle free blood collection device, which allows ... |
| - | Medical device startup benefits from Philadelphia seed fund | Two years after the city of Philadelphia launched a $3 million seed fund, the fund has invested in a medical device company — one of four companies to receive investments topping $700,000 and the only healthcare business among them.
Velano ... |
| - | Velano Vascular partners with Sutter Health to scale novel blood draw device business | Velano Vascular’s FDA-cleared PIVO device
Hospital patients are often the recipients of an unpleasant early-morning ritual: a wake-up call at 4:30 by a nurse who needs to draw blood to ensure it goes to processing before doctors do their mo... |
